Portfolio company
Aperiam Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
The company uses computer vision to design stable, high-performing proteins for customers in the cosmetics, therapeutics, and technical reagents sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Open Protein
This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.
Aikium
This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.
Profluent Bio
Profluent Bio develops generative artificial intelligence models to design novel functional proteins for biopharmaceutical companies and industrial partners.
Aether Biomachines
Aether Biomachines develops AI-designed proteins and enzymes for industrial manufacturing, mineral processing, and advanced materials customers in defense, aerospace, and chemicals.
AI Proteins
This deep-tech company designs engineered miniprotein biologics for patients and pharmaceutical partners using artificial intelligence and synthetic biology.
AETHER BIO
Aether Bio develops AI-designed proteins and enzymes for customers in the industrial manufacturing, aerospace, and critical mineral extraction sectors.
Anthrogen
This company develops artificial intelligence models and experimental infrastructure to design modular proteins and biological machines for healthcare, industrial and climate applications.
Diffuse Bio
This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.
